Pearls for Implementing EMR in Ophthalmic Practice

Pearls for Implementing EMR in Ophthalmic Practice

Dr. Lauren Shatz offers some pearls for transitioning to EMR in ophthalmic practice. Dr. Shatz discusses choosing EMR, nuances of EMR modules, as well as the initial time investment that it takes to implement EMR. Dr. Shatz also touches on the efficiencies that are the payoff for transitioning to EMR.

more

Optronics Microcast HD Studio Camera

Optronics Microcast HD Studio Camera

Microcast HD Studio is a medical grade high definition microsurgical imaging system developed for ophthalmic microsurgery. The full-high definition imaging system produces uncompressed 1920x1080p images with superior color accuracy, detail and depth perception of microsurgical fields, delivering 60 images per second.

Microcast HD Studio, captures full HD stills and presentation quality progressive scan MPEG-4 H.264 video without a computer, allowing the surgeon to focus on surgery not camera programming or complicated video editing.

more

News

9/1/2010

LEDs Illuminate Eye For Ocular Disease Screening

A new imaging system using six different wavelengths to illuminate the interior of the eyeball (ocular fundus) may pave the way for doctors to easily screen patients for common diseases of the eye, such as age-related macular degeneration and diabetic retinopathy. The system is described in the journal Review of Scientific Instruments, which is published by the American Institute of Physics.

Source: American Institute of Physics


8/31/2010

Alimera Sciences' Iluvien(R) Receives FDA Priority Review for the Treatment of Diabetic Macular Edema

ATLANTA, Aug 30, 2010 (GlobeNewswire via COMTEX News Network) -- Alimera Sciences, Inc., (Nasdaq:ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that the Company's New Drug Application (NDA) for Iluvien(R) (fluocinolone acetonide intravitreal insert) has been accepted for filing and granted Priority Review status by the U.S. Food and Drug Administration (FDA).

Source: Alimera Sciences, Inc

More News Articles

advertisement
Advertisement (image not found)

Advertise With Us

Vendors, get information about advertising, sponsorship opportunities, multimedia production, and listing your products on OphthalmologyWeb.

Learn more about advertising

Sponsored by

The most likely diagnosis is:




 
advertisement
Here"s the HTML to use:

You do not have JavaScript enabled or are using an older version of Adobe Flash. You can update your version of Adobe Flash here.

Upcoming Events

Newsletters













Write For Us

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing